{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:56:55Z","timestamp":1791280615124,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs - Real World Outcomes"],"DOI":"10.1007\/s40801-026-00584-4","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:40:53Z","timestamp":1791279653000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Pharmacist-Led Polypharmacy Management on Prescribing Patterns in Older Inpatients: A Real-World Study in a Chronic Care Hospital"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8056-438X","authenticated-orcid":false,"given":"Takefumi","family":"Miyake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Masui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideko","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiyasu","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Kadowaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"584_CR1","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s41999-021-00479-3","volume":"12","author":"F Pazan","year":"2021","unstructured":"Pazan F, Wehling M. Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences. Eur Geriatr Med. 2021;12:443\u201352. https:\/\/doi.org\/10.1007\/s41999-021-00479-3.","journal-title":"Eur Geriatr Med"},{"key":"584_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1517\/14740338.2013.827660","volume":"13","author":"RL Maher","year":"2014","unstructured":"Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13:57\u201365. https:\/\/doi.org\/10.1517\/14740338.2013.827660.","journal-title":"Expert Opin Drug Saf"},{"key":"584_CR3","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1080\/14740338.2018.1546841","volume":"17","author":"JW Wastesson","year":"2018","unstructured":"Wastesson JW, Morin L, Tan ECK, Johnell K. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opin Drug Saf. 2018;17:1185\u201396. https:\/\/doi.org\/10.1080\/14740338.2018.1546841.","journal-title":"Expert Opin Drug Saf"},{"key":"584_CR4","doi-asserted-by":"publisher","first-page":"e0305215","DOI":"10.1371\/journal.pone.0305215","volume":"19","author":"S Chua","year":"2024","unstructured":"Chua S, Todd A, Reeve E, Smith SM, Fox J, Elsisi Z, et al. Deprescribing interventions in older adults: an overview of systematic reviews. PLoS ONE. 2024;19:e0305215. https:\/\/doi.org\/10.1371\/journal.pone.0305215.","journal-title":"PLoS ONE"},{"key":"584_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","volume":"57","author":"AA Mangoni","year":"2004","unstructured":"Mangoni AA, Jackson SHD. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57:6\u201314. https:\/\/doi.org\/10.1046\/j.1365-2125.2003.02007.x.","journal-title":"Br J Clin Pharmacol"},{"key":"584_CR6","doi-asserted-by":"publisher","first-page":"e074892","DOI":"10.1136\/bmj-2023-074892","volume":"385","author":"A Hung","year":"2024","unstructured":"Hung A, Kim YH, Pavon JM. Deprescribing in older adults with polypharmacy. BMJ. 2024;385:e074892. https:\/\/doi.org\/10.1136\/bmj-2023-074892.","journal-title":"BMJ"},{"key":"584_CR7","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.1007\/s00520-018-4281-3","volume":"26","author":"A Whitman","year":"2018","unstructured":"Whitman A, DeGregory K, Morris A, Mohile S, Ramsdale E. Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study. Support Care Cancer. 2018;26:4105\u201313. https:\/\/doi.org\/10.1007\/s00520-018-4281-3.","journal-title":"Support Care Cancer"},{"key":"584_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12877-025-06964-9","volume":"26","author":"ZT Tesfaye","year":"2026","unstructured":"Tesfaye ZT, Horsa BA, Yismaw MB. Impact of pharmacist-led deprescribing interventions on medication related outcomes among older adults: a systematic review and meta-analysis. BMC Geriatr. 2026;26:181. https:\/\/doi.org\/10.1186\/s12877-025-06964-9.","journal-title":"BMC Geriatr"},{"key":"584_CR9","doi-asserted-by":"publisher","first-page":"734045","DOI":"10.3389\/fphar.2021.734045","volume":"12","author":"M Kurczewska-Michalak","year":"2021","unstructured":"Kurczewska-Michalak M, Lewek P, Jankowska-Pola\u0144ska B, et al. Polypharmacy management in older adults: a scoping review of available interventions. Front Pharmacol. 2021;12:734045.","journal-title":"Front Pharmacol"},{"key":"584_CR10","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.3390\/jcm13123529","volume":"13","author":"L Perrella","year":"2024","unstructured":"Perrella L, Mucherino S, Casula M, Illario M, Orlando V, Menditto E. Polypharmacy management in chronic conditions: a systematic literature review of Italian interventions. J Clin Med. 2024;13:3529.","journal-title":"J Clin Med"},{"key":"584_CR11","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s41999-023-00872-0","volume":"14","author":"E van Poelgeest","year":"2023","unstructured":"van Poelgeest E, Seppala L, Bahat G, Ilhan B, Mair A, van Marum R, et al. Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy: EuGMS SIG on pharmacology position paper. Eur Geriatr Med. 2023;14:1195\u2013209. https:\/\/doi.org\/10.1007\/s41999-023-00872-0.","journal-title":"Eur Geriatr Med"},{"key":"584_CR12","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1186\/s12877-022-03279-x","volume":"22","author":"M Delara","year":"2022","unstructured":"Delara M, Murray L, Jafari B, Bahji A, Goodarzi Z, Kirkham J, et al. Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis. BMC Geriatr. 2022;22:601. https:\/\/doi.org\/10.1186\/s12877-022-03279-x.","journal-title":"BMC Geriatr"},{"key":"584_CR13","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2026; 2026. Oslo: WHO Collaborating Centre. https:\/\/atcddd.fhi.no\/atc_ddd_index_and_guidelines. Accessed 11 Mar 2026."},{"key":"584_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3390\/pharmacy13040109","volume":"13","author":"F McGrory","year":"2025","unstructured":"McGrory F, Elnaem MH. Pharmacist-led interventions for polypharmacy management in older adults: a systematic review of strategies and outcomes in the United Kingdom and the Republic of Ireland. Pharmacy (Basel). 2025;13:109. https:\/\/doi.org\/10.3390\/pharmacy13040109.","journal-title":"Pharmacy (Basel)"},{"key":"584_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1146\/annurev-med-070822-101947","volume":"75","author":"W Thompson","year":"2024","unstructured":"Thompson W, McDonald EG. Polypharmacy and deprescribing in older adults. Annu Rev Med. 2024;75:113\u201327. https:\/\/doi.org\/10.1146\/annurev-med-070822-101947.","journal-title":"Annu Rev Med"},{"key":"584_CR16","doi-asserted-by":"publisher","first-page":"e259375","DOI":"10.1001\/jamanetworkopen.2025.9375","volume":"8","author":"AM Linsky","year":"2025","unstructured":"Linsky AM, Motala A, Booth M, Lawson E, Shekelle PG. Deprescribing in community-dwelling older adults: a systematic review and meta-analysis. JAMA Netw Open. 2025;8:e259375. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.9375.","journal-title":"JAMA Netw Open"},{"key":"584_CR17","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.jval.2025.10.001","volume":"29","author":"Y Zhang","year":"2026","unstructured":"Zhang Y, Chen Z, Chen X, Tian F. Economic evaluation of deprescribing in older adults: a systematic review. Value Health. 2026;29:521\u20139. https:\/\/doi.org\/10.1016\/j.jval.2025.10.001.","journal-title":"Value Health"},{"key":"584_CR18","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1186\/s12913-021-07125-5","volume":"21","author":"M Pyyk\u00f6nen","year":"2021","unstructured":"Pyyk\u00f6nen M, Linna M, Tykkyl\u00e4inen M, Delmelle E, Laatikainen T. Patient-specific and healthcare real-world costs of atrial fibrillation in individuals treated with direct oral anticoagulant agents or warfarin. BMC Health Serv Res. 2021;21:1299. https:\/\/doi.org\/10.1186\/s12913-021-07125-5.","journal-title":"BMC Health Serv Res"},{"key":"584_CR19","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1016\/j.jamda.2023.07.016","volume":"24","author":"D Zhou","year":"2023","unstructured":"Zhou D, Chen Z, Tian F. Deprescribing interventions for older patients: a systematic review and meta-analysis. J Am Med Dir Assoc. 2023;24:1718\u201325. https:\/\/doi.org\/10.1016\/j.jamda.2023.07.016.","journal-title":"J Am Med Dir Assoc"}],"container-title":["Drugs - Real World Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-026-00584-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40801-026-00584-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-026-00584-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:40:55Z","timestamp":1791279655000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40801-026-00584-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":19,"alternative-id":["584"],"URL":"https:\/\/doi.org\/10.1007\/s40801-026-00584-4","relation":{},"ISSN":["2199-1154","2198-9788"],"issn-type":[{"value":"2199-1154","type":"print"},{"value":"2198-9788","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"3 September 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","label":"Conflicts of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethical Review Committees of Omi Medical Center and Omi Fureai Hospital in accordance with the Code of Ethics of the Corporation (2025-0119).","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was waived because this was a retrospective, observational study that used anonymized data obtained from existing medical records, in accordance with the Ethical Guidelines for Medical and Health Research Involving Human Subjects in Japan.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}